Symposium on Dose Selection for Cancer Treatment
Drugs
Event Organizers:
Stanford Cancer Institute
(SCI), Stanford Center for Innovative Study Design
(CISD), UCSF - Stanford Center of Excellence
in Regulatory Science and Innovation (CERSI), University
of Chicago Comprehensive Cancer Center
Symposium
Objective: The goal of this workshop is to exchange
research progress and discuss challenges in appropriate dosage
for cancer treatments.
Both
academic institutions and pharmaceutical industry have conducted early phase
trials to select appropriate doses for later development of cancer treatments.
The increasing need for the development of combination therapy due to
resistance to monotherapy and poor tolerance of approved dose regimens
underscores the need for a more efficient process of dose selection in the
early stages of study design and refinement through the whole cycle of drug
development and post-marketing research. Furthermore, with gaining insights of
pharmacology and pharmacogenomics, multidisciplinary approaches are necessary
to understand the exposure - response relationships, genomic modifications,
modeling and simulation for dose findings, and new design for dose-optimization
studies. This symposium will bring together researchers from academia and
pharmaceutical industry to exchange research progress and discuss common
challenges in appropriate dosage for cancer treatments.
Program, Date and Location (searchable
Stanford map: https://campus-map.stanford.edu):
May 11, 2017. Short course on
“Phase I/II Clinical Trial Design and Dose Finding”
8:30am-4:00pm,
Alway Building M106, 300 Pasteur Drive, Stanford, CA, United States Instructors:
Naitee Ting, Ph.D., and Qiqi Deng, Ph.D.,
Beohringer-Ingelheim, Inc., Editor of the book published by Springer,
2006.
May 12, 2017. Symposium Program
on Dose Selection for Cancer Treatments
8:20am-12:00pm,
Munzer Auditorium, Beckmann Center, 279 Campus Drive West,
Ground Floor, Stanford,
CA 94305
1:00pm-6:00pm,
LK 130, Li Ka Shing Center for
Learning and Knowledge (LKSC), 291 Campus Drive, 1st Floor, Stanford, CA 94305
Keynote Speakers:
•
Dr. Rajeshwari Sridhara, Ph.D.,
Director of Division of Biometrics V, CDER, US FDA
•
Dr. Shivaani Kummar, MD, FACP, Professor and Director, Phase I Clinical Research Program, Division of Oncology, Stanford Cancer
Institute, Stanford University
• Dr. Peter Mueller,
Ph.D., Professor, Division of Statistics and Scientific Computation, Department of Mathematics, University of Texas,
Austin
Organization
Committee: Ying Lu, Ph.D.
(Co-Chair, Stanford University); Yuan Ji, Ph.D. (Co-Chair, University of
Chicago); Philip Lavori, Ph.D. (Stanford
University), Tze L. Lai Ph.D. (Stanford
University), Shivaani Kummar, MD (Stanford
University)
Registration and
more detailed information about this Symposium:
http://med.stanford.edu/cisd/events/symposium-May2017.html